Lattice Biologics Ltd. (LBLTF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 3, 2025
Lattice Biologics Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | 2015 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '21 Jun 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | 2015 - 2014 |
| Cash & Equivalents | - | 0.06 | 0.02 | 0.01 | 0.02 | 0.05 | Upgrade
|
| Cash & Short-Term Investments | - | 0.06 | 0.02 | 0.01 | 0.02 | 0.05 | Upgrade
|
| Cash Growth | - | 265.18% | 143.01% | -65.74% | -64.72% | 6.08% | Upgrade
|
| Receivables | - | 0.29 | 0.26 | 0.17 | 0.22 | 0.42 | Upgrade
|
| Inventory | - | 0.52 | 0.7 | 1.48 | 1.85 | 2.2 | Upgrade
|
| Prepaid Expenses | - | 0.04 | 0.06 | 0.02 | 0 | 0.1 | Upgrade
|
| Total Current Assets | - | 0.9 | 1.04 | 1.68 | 2.09 | 2.78 | Upgrade
|
| Property, Plant & Equipment | - | 1.51 | 0.49 | 0.51 | 0.34 | 0.68 | Upgrade
|
| Goodwill | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | Upgrade
|
| Other Intangible Assets | - | - | 0.14 | 0.28 | 0.42 | 0.55 | Upgrade
|
| Total Assets | 0.61 | 3.02 | 2.27 | 3.07 | 3.45 | 4.62 | Upgrade
|
| Accounts Payable | 0.51 | 3.56 | 3.19 | 2.93 | 2.52 | 2.75 | Upgrade
|
| Accrued Expenses | - | 1.65 | 2.27 | 2.29 | 1.68 | 2.29 | Upgrade
|
| Short-Term Debt | - | - | - | 0.01 | 0.11 | 0.12 | Upgrade
|
| Current Portion of Long-Term Debt | - | 2.09 | 1.89 | 1.27 | 1.8 | 2.21 | Upgrade
|
| Current Portion of Leases | - | 0.16 | 0.04 | 0.03 | 0.02 | 0.03 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.03 | - | - | Upgrade
|
| Other Current Liabilities | - | 0.37 | 0.3 | 0.42 | 0.41 | 0.38 | Upgrade
|
| Total Current Liabilities | 0.51 | 7.83 | 7.68 | 6.97 | 6.53 | 7.79 | Upgrade
|
| Long-Term Debt | - | 0.34 | 0.2 | 0.7 | 0.44 | 0.55 | Upgrade
|
| Long-Term Leases | - | 0.54 | 0 | 0.01 | 0.04 | 0.05 | Upgrade
|
| Other Long-Term Liabilities | - | 0.7 | 0.7 | 0.7 | 0.7 | 2.12 | Upgrade
|
| Total Liabilities | 0.51 | 9.42 | 8.59 | 8.39 | 7.71 | 10.51 | Upgrade
|
| Common Stock | 11.01 | 11.01 | 9.62 | 9.62 | 9.6 | 6.74 | Upgrade
|
| Retained Earnings | -10.93 | -17.91 | -16.43 | -15.41 | -14.18 | -12.66 | Upgrade
|
| Comprehensive Income & Other | 0.02 | 0.49 | 0.49 | 0.47 | 0.32 | 0.02 | Upgrade
|
| Shareholders' Equity | 0.1 | -6.4 | -6.31 | -5.32 | -4.26 | -5.89 | Upgrade
|
| Total Liabilities & Equity | 0.61 | 3.02 | 2.27 | 3.07 | 3.45 | 4.62 | Upgrade
|
| Total Debt | - | 3.14 | 2.13 | 2.03 | 2.41 | 2.96 | Upgrade
|
| Net Cash (Debt) | - | -3.08 | -2.12 | -2.02 | -2.39 | -2.91 | Upgrade
|
| Net Cash Per Share | - | -0.03 | -0.02 | -0.02 | -0.03 | -0.06 | Upgrade
|
| Filing Date Shares Outstanding | 128.22 | 128.22 | 93.46 | 93.46 | 93.29 | 63.14 | Upgrade
|
| Total Common Shares Outstanding | 128.22 | 128.22 | 93.46 | 93.46 | 93.29 | 63.14 | Upgrade
|
| Working Capital | -0.51 | -6.93 | -6.65 | -5.3 | -4.44 | -5.01 | Upgrade
|
| Book Value Per Share | 0.00 | -0.05 | -0.07 | -0.06 | -0.05 | -0.09 | Upgrade
|
| Tangible Book Value | -0.51 | -7.01 | -7.06 | -6.21 | -5.29 | -7.05 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | -0.05 | -0.08 | -0.07 | -0.06 | -0.11 | Upgrade
|
| Machinery | - | 0.76 | 0.61 | 0.56 | 0.54 | 0.56 | Upgrade
|
| Construction In Progress | - | 0.42 | 0.21 | 0.21 | - | - | Upgrade
|
| Leasehold Improvements | - | 0.38 | - | - | - | 0.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.